Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 13, 2026Neurology

Real-World Efficacy and Safety of Inebilizumab in Generalized Myasthenia Gravis (P9-9.014)

View Full Paper
Ask AI
Bookmark
Share

Authors

HLH J LiCZChao ZhangDJDongmei Jia

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates efficacy and safety of inebilizumab in generalized myasthenia gravis, suggesting benefits in treatment.

Key Points

  • This research aims to assess how effective and safe inebilizumab is for treating generalized myasthenia gravis.
  • Real-world evaluation of inebilizumab in patients diagnosed with generalized myasthenia gravis.
  • Assessment of patient-reported outcomes and safety metrics.
  • Patients showed significant improvement in muscle strength and reduced symptoms after treatment with inebilizumab.
  • Safety profile indicated manageable side effects, suggesting a favorable treatment option.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf3b4faef96ed7f0561echttps://doi.org/10.1212/wnl.0000000000215703
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluating inebilizumab in the treatment of generalized myasthenia gravis2025 · 1 citations
  2. 2Evaluating inebilizumab in the treatment of generalized myasthenia gravis2025
  3. 3Rescue Treatment of Inebilizumab in Refractory Myasthenia Gravis: A Case Report (P11-9.004)2026
  4. 4Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy, Pharmacodynamics, and Immunogenicity in AChR+ Cohort (Week 52) (S14.009)2026
  5. 5Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial2026 · 1 citations